SS Innovations International Inc. Common Stock

SS Innovations International Inc. Common Stock

SSII · NASDAQ · Healthcare / Medical Devices

1.66USD+0.34 (+25.76%)

Price History

Full chart

Market Stats

Previous Close1.32
Open1.32
Day Range1.26 – 1.82
52-Week Range2.87 – 10.00
Volume634.61K
Market Cap579.11M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.06
Dividend Yield0.00%
Beta0.58
50-Day Avg3.53
200-Day Avg4.25

About

SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems. The company also develops NADI " Automated Coronary Anastomotic Connector, a micro stapling device; SSi Multi-Fire Clip Applier, a cartridge-based clip applicator; SSi Robotic Stapler; SSi Maya is an enabling digital platform that compliments the SSI Mantra system and enhances surgical capabilities; SSi Guru is a virtual tele illustration; SSi XR Cognitive Skill Simulator is an extended reality (XR) software platform developed to train and educate surgeons and surgical assistants; SSi MantraM; SSi Mantra Tele Surgeon Console (TSC); and 5mm surgical instruments; SSi Holographic Anatomy, an augmented reality tool; SSi Chitrasa " Advanced DICOM Viewer, an AI enabled application viewer; and SSi Mixed Reality Headset, a medical-grade device. In addition, it offers instrument tips, including forceps, scissors, electrocautery tools, scalpels, and other surgical tools. Further, the company provides accessory products, such as sterile drapes, 3d stereo endoscopes, cannulas, and seals, as well as tele proctoring and telesurgery products. Additionally, it offers installation, repair, maintenance, 24/7 technical support, and proactive health monitoring services. The company sells its products through direct sales organizations and distributor networks. SS Innovations International, Inc. is headquartered in Gurugram, India.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. Sudhir Prem Srivastava M.D.
  • Employees483
  • Headquarters405, iLabs Info Technology Centre, Gurugram, India, 122016, USA
  • Websitehttps://ssinnovations.com

Leadership

  • Dr. Sudhir Prem Srivastava M.D.Founder, CEO & Chairman · b. 1948
  • Dr. Vishwajyoti P. Srivastava M.D.Chief Executive Officer of APAC & Director · b. 1978
  • Mr. Barry F. CohenCOO of Americas & Director · b. 1940
  • Amit GargManager of Finance & Accounts
  • Vilayat AliHead of Marketing & Digital Media
  • Amitesh NigamHead of Human Resources
  • Mr. Colin EkeSenior Vice President of Global Business Development
  • Rama Krishna ReddyCTO of South Asia
  • Mr. Avinash KumarChief Operating Officer of India
  • Mr. Rahul KumarHead of IP

Financials

Income Statement

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue----0001.46M5.88M20.65M42.48M
Growth (%)--------+303.19%+251.20%+105.74%
Cost of Revenue--78919.46K37.70K37.43K37.70K968.72K5.17M12.20M22.94M
Gross Profit---789-19.46K-37.70K-37.43K-37.70K489.59K713.45K8.45M19.54M
Gross Margin-------33.57%12.13%40.93%46.00%
Operating Expense--1.01M940.92K3.28M1.07M3.28M6.17M21.38M27.43M27.74M
Operating Income-66-462.49K-1.01M-960.38K-3.32M-1.10M-3.32M-5.68M-20.67M-18.98M-8.19M
Operating Margin--------389.44%-351.52%-91.90%-19.29%
EBITDA-66-462.46K-1.01M-940.86K-3.33M-1.09M-3.33M-5.31M-20.26M-17.74M-5.98M
EBITDA Margin--------364.16%-344.51%-85.92%-14.07%
Net Income-66-484.98K-1.04M-960.32K-3.39M-1.12M-3.39M-5.60M-20.94M-19.15M-12.13M
Net Income Margin--------384.11%-356.17%-92.74%-28.55%
R&D-138.38K71.17K27.13K60.87K3.00K60.87K83.28K576.17K2.49M3.69M
R&D as % of Total Revenue-------5.71%9.80%12.07%8.68%
Interest Expense-22.52K27.00K-12.76K1.06K0162.00K523.36K973.24K1.11M
Interest Expense % of Total Revenue-------11.11%8.90%4.71%2.61%

Balance Sheet

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-292.23K509.96K145.43K132.52K317.87K132.52K6.98M25.48M42.39M74.23M
Total Liabilities-647.29K408.87K449.78K1.20M1.19M1.20M9.66M11.18M28.93M36.01M
Total Equity--355.06K101.09K-223.04K-1.06M-869.05K-1.06M-2.68M14.30M13.46M38.22M
Cash-248.22K452.57K35.72K28.47K160.71K28.47K217.18K7.03M466.50K3.21M
Total Debt-480.00K-30.00K457.50K195.00K457.50K8.27M8.22M18.20M14.36M
Net Debt-231.78K-452.57K-5.72K429.03K34.29K429.03K8.05M1.19M17.74M11.15M

Cash Flow

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-190.23K-446.86K-443.29K-424.11K-90.54K-424.11K-5.99M-15.36M-9.50M-18.54M
Investing Cash Flow-43.55K-4.17K-23.57K-50.12K-44.00K-50.12K240.82K-453.33K-661.48K-3.66M
Financing Cash Flow481.90K655.38K50.00K466.99K266.77K466.99K5.90M22.80M9.43M26.17M
Capital Expenditure43.55K4.17K23.57K50.12K4.00K50.12K4.56M453.33K661.48K3.66M
Free Cash Flow-233.78K-451.03K-466.86K-474.23K-94.54K-474.23K-1.44M-15.81M-10.16M-22.20M
FCF to OCF122.89%100.93%105.32%111.82%104.42%111.82%23.95%102.95%106.96%119.73%

Earnings

Report DateDec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Mar 22, 2024May 15, 2024Aug 12, 2024Nov 11, 2024Mar 20, 2025May 13, 2025Aug 7, 2025Oct 28, 2025Mar 10, 2026May 14, 2026Aug 13, 2026Oct 27, 2026
EPS Estimate-------------------------------0.01-0.01
EPS Actual-0.10-0.15-0.18-0.49-0.74-0.13-0.10-0.17-0.09-0.11-0.15-0.15-0.10-0.02-0.04-0.20-0.22-0.32-0.04-0.01-0.09-0.02-0.02-0.04-0.01-0.03-0.00-0.02-0.01-0.02-0.01-
Surprise------------------------------0.00%-
Timing--------------------After-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-market--After-hoursAfter-hoursPre-marketPre-market

Key Statistics & Ratios

Market Cap579.11M
Enterprise Value627.42M
Trailing P/E0.00
Forward P/E0.00
Price / Sales11.05
Price / Book11.67
EPS-0.06
Book Value0.272
Revenue (TTM)52.40M
Gross Profit (TTM)24.97M
EBITDA-7.19M
Profit Margin-23.73%
Operating Margin-16.29%
Return on Equity-26.06%
Return on Assets-6.34%
Shares Outstanding200.39M
Shares Float40.62M
Beta0.58
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
0.85%
Insiders
80.11%
Retail / Other
19.04%

Top Institutional Holders

  • Hood River Capital Management LLC
    833.33K0.42%
  • CWM Advisors, LLC
    186.30K0.09%
  • UBS Group AG
    155.54K0.08%
  • Handelsbanken Fonder AB
    120.00K0.06%
  • Eversept Partners, LP
    110.16K0.06%
  • Jnba Financial Advisors Inc
    102.29K0.05%
  • AlphaCentric Advisors, LLC
    50.00K0.03%
  • Forum Financial Management, LP
    38.47K0.02%
  • Geode Capital Management, LLC
    36.28K0.02%
  • AlTi Global Inc
    20.55K0.01%
  • Mariner Wealth Advisors LLC
    18.66K0.01%
  • Y-Intercept (Hong Kong) Ltd
    17.93K0.01%
  • IFC & Insurance Marketing, Inc.
    16.73K0.01%
  • State Street Corp
    15.59K0.01%

Top Fund Holders

  • Hood River International Opp Instl
    833.33K0.42%
  • Inspire Small/Mid Cap ETF
    186.30K0.09%
  • Handelsbanken Hälsovård Tema (A1 SEK)
    120.00K0.06%
  • AlphaCentric Robotics and Automation I
    50.00K0.03%
  • Fidelity Nasdaq Composite Index
    47.94K0.02%
  • State Street® SPDR® S&P® EM Sm Cp ETF
    14.22K0.01%

Stock Splits

  • Apr 17, 20231:10